PT1853296E - Utilização de um undecapeptídeo cíclico para a preparação de um medicamento para administração em situações de miocardia isquêmica - Google Patents

Utilização de um undecapeptídeo cíclico para a preparação de um medicamento para administração em situações de miocardia isquêmica Download PDF

Info

Publication number
PT1853296E
PT1853296E PT06704161T PT06704161T PT1853296E PT 1853296 E PT1853296 E PT 1853296E PT 06704161 T PT06704161 T PT 06704161T PT 06704161 T PT06704161 T PT 06704161T PT 1853296 E PT1853296 E PT 1853296E
Authority
PT
Portugal
Prior art keywords
cyclic undecapeptide
undecapeptide
formula
cyclic
reperfusion
Prior art date
Application number
PT06704161T
Other languages
English (en)
Portuguese (pt)
Inventor
Pietro Scalfaro
Jean-Maurice Dumont
Gregoire Vuagniaux
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Publication of PT1853296E publication Critical patent/PT1853296E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT06704161T 2005-01-10 2006-01-10 Utilização de um undecapeptídeo cíclico para a preparação de um medicamento para administração em situações de miocardia isquêmica PT1853296E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05000357 2005-01-10

Publications (1)

Publication Number Publication Date
PT1853296E true PT1853296E (pt) 2012-09-26

Family

ID=34933239

Family Applications (1)

Application Number Title Priority Date Filing Date
PT06704161T PT1853296E (pt) 2005-01-10 2006-01-10 Utilização de um undecapeptídeo cíclico para a preparação de um medicamento para administração em situações de miocardia isquêmica

Country Status (9)

Country Link
US (1) US8889629B2 (enExample)
EP (1) EP1853296B1 (enExample)
JP (1) JP2008526816A (enExample)
DK (1) DK1853296T5 (enExample)
ES (1) ES2387682T3 (enExample)
PL (1) PL1853296T3 (enExample)
PT (1) PT1853296E (enExample)
SI (1) SI1853296T1 (enExample)
WO (1) WO2006072639A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2023948A1 (en) * 2006-05-04 2009-02-18 Michel Ovize Use of cyclosporin a or melle4-cyclosporin for the treatment of acute myocardial infarction
WO2009098533A1 (en) * 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy
WO2011141891A1 (en) 2010-05-12 2011-11-17 Debio Recherche Pharmaceutique S.A. Use of cycloundecadepsipeptide compounds
GB201217560D0 (en) 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
US9579100B2 (en) * 2013-03-15 2017-02-28 Boston Scientific Scimed, Inc. System for controlling a tissue-stapling operation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673768B1 (en) * 1997-10-16 2004-01-06 Board Of Regents, The University Of Texas System Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating)
US6492401B1 (en) * 1998-02-27 2002-12-10 Pfizer, Inc. N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
EP1091975B1 (fr) * 1998-07-01 2005-12-14 Debiopharm S.A. Nouvelle cyclosporine ayant un profil d'activite ameliore
ATE330968T1 (de) * 1999-02-05 2006-07-15 Debiopharm Sa Cyclosporin-derivate und verfahren zu deren herstellung

Also Published As

Publication number Publication date
DK1853296T5 (da) 2013-03-18
WO2006072639A1 (fr) 2006-07-13
EP1853296B1 (fr) 2012-06-20
ES2387682T3 (es) 2012-09-28
DK1853296T3 (da) 2012-09-03
SI1853296T1 (sl) 2012-10-30
EP1853296A1 (fr) 2007-11-14
PL1853296T3 (pl) 2012-12-31
US20090023640A1 (en) 2009-01-22
JP2008526816A (ja) 2008-07-24
US8889629B2 (en) 2014-11-18

Similar Documents

Publication Publication Date Title
ES2611187T3 (es) Tratamiento para hipertensión pulmonar
Silachev et al. The mitochondrion as a key regulator of ischaemic tolerance and injury
CN104619710B (zh) 用于治疗再灌注损伤的氧杂二环庚烷和氧杂二环庚烯
Cheng et al. Anaesthesia for non-cardiac surgery in heart-transplanted patients
WO2002053167A2 (es) Combinacion farmaceutica para el tratamiento del dano tisular debido a falta de irrigacion sanguinea arterial
US20180214400A1 (en) The use of kauranes compounds in the manufacture of medicament for treatment of cadiac hypertropy and pulmonary hypertension
CN115813916A (zh) I3c在制备预防和/或治疗心力衰竭疾病药物中的用途
ES2651492T3 (es) Composición acuosa pulverizable que comprende trinitrato de glicerilo
Dai et al. Effects of OP2113 on myocardial infarct size and No reflow in a rat myocardial ischemia/reperfusion model
Thokala et al. Loss of ErbB2-PI3K/Akt signaling prevents zinc pyrithione-induced cardioprotection during ischemia/reperfusion
PT1853296E (pt) Utilização de um undecapeptídeo cíclico para a preparação de um medicamento para administração em situações de miocardia isquêmica
JP2002534379A (ja) 新規なブレチリウム組成物およびキットならびに心血管症状の予防および治療におけるそれらの使用
TW201806590A (zh) 用於治療缺血再灌注損傷之戊二酸酯化合物
US5631226A (en) Treatment to reduce edema
WO2007143897A1 (fr) Composé présentant une propriété spéciale, composition comprenant le composé, et sa préparation et ses utilisations
Fan et al. Remote ischemic preconditioning improves post resuscitation cerebral function via overexpressing neuroglobin after cardiac arrest in rats
CN106421746B (zh) [Pyr1]‑Apelin‑13作为长效酰胺类局麻药中毒所致心脏停搏的抢救药物的应用
JP2018537522A (ja) 組合せ
CN117257803B (zh) 鲁拉西酮在制备治疗或预防缺血/再灌注损伤的药物和细胞保护药物中的应用
WO1999040919A1 (en) Remedies for cardiac dilastolic disorders
WO2016086327A1 (es) Formulación antioxidante inyectable de uso intravenoso de ascorbato de sodio - en altas dosis, n-acetilcisteína, y deferoxamina; método de administración y uso en prevenir daño por reperfusión; y kit
AU2013237021A1 (en) Compounds for the treatment of ischemia-reperfusion- related diseases
WO2001097831A1 (fr) Agents therapeutiques et prophylactiques destines a l'insuffisance cardiaque
JP2000026295A (ja) 虚血再潅流損傷の治療薬ならび不整脈および心筋梗塞による心不全を含む細胞機能障害の治療薬
ES2235829T3 (es) Utilizacion de moxonidina para el tratamiento post-infarto de corazon.